ARMP
Armata Pharmaceuticals Inc
4.30$
+1.9%
vs. previous close
Closing price · As of: Sep 21, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | – | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| – | – | 141.9% | 325.2% | – | 4,358.1% | 1,755.0% | 447.4% | 635.7% | 21.5% | 665.4% | 31.2% | |
| 100.0% | 100.0% | -41.9% | -225.2% | – | -4,358.1% | -1,655.0% | -347.4% | -535.7% | 78.5% | -565.4% | 68.8% | |
| 1,419.3% | 840.4% | 2,183.8% | 2,505.2% | – | 31,690.3% | 1,755.0% | 447.4% | 635.7% | 745.6% | 665.4% | 483.6% | |
| 1,674.8% | 1,412.6% | 3,235.8% | 6,600.0% | – | 29,887.1% | 967.9% | 185.1% | 135.0% | 257.2% | 254.8% | 253.0% | |
| 3,549.9% | 2,253.1% | 9,091.5% | 14,148.7% | – | 57,219.4% | 967.9% | 185.1% | 135.0% | 981.4% | 254.8% | 705.4% | |
| -3,449.9% | -2,153.1% | -8,991.5% | -14,048.7% | – | -61,577.4% | -2,623.0% | -532.5% | -670.8% | -902.8% | -820.2% | -636.7% | |
| 0.0% | 0.0% | 0.0% | 0.0% | – | 3,003.2% | 76.3% | 1.4% | 0.5% | 58.0% | 207.6% | 338.3% | |
| 5,650.1% | -124.0% | -7,459.2% | -12,295.7% | – | -62,835.5% | -2,695.1% | -517.5% | -670.2% | -1,524.5% | -365.6% | -3,544.0% | |
| -9,100.0% | -15.4% | -213.8% | -1,132.2% | – | -1,464.5% | 77.0% | 1.4% | -0.5% | – | – | – | |
| 5,650.1% | -108.6% | -7,245.4% | -11,163.5% | – | -62,835.5% | -2,695.1% | -517.5% | -670.2% | -1,524.5% | -365.6% | -3,544.0% | |
| -2,955.5% | -2,153.1% | -5,177.7% | -8,680.0% | – | -55,474.2% | -2,483.5% | -490.0% | -653.5% | -1,445.1% | -132.4% | -3,174.5% |
Data as of: September 21, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.